CureVac Continues Covid-19 Vaccine Funding Frenzy with €180M IPO
The share price of CureVac has skyrocketed almost fivefold after the Covid-19 vaccine developer priced…
17/08/2020 - 3 minutes
Covid-19
Oxford Nanopore’s Portable Covid-19 Test Launched in UK
UK biotech Oxford Nanopore has launched a portable test that can detect both Covid-19 and…
05/08/2020 - 4 minutes
Llama-Derived Nanobodies Join the Fight Against Covid-19
Newly-launched Belgian startup ExeVir Bio will develop ‘nanobodies’ that bind very precisely to key areas…
30/07/2020 - 3 minutes
Covid-19 Forces Gene Therapy Companies to Shift Strategy
Amid the Covid-19 pandemic, gene therapy companies are suffering, with clinical trials delayed and investors…
29/07/2020 - 4 minutes
Inhaled Treatment Reduces Severe Covid-19 Risk by 79%
An experimental Covid-19 treatment that is delivered directly to the lungs via a nebulizer reduced…
22/07/2020 - 3 minutes
Russian Hackers Launch Cyber Attack on Covid-19 Vaccine Developers
The National Cyber Security Centre (NCSC) in the UK stated this week that several organizations…
17/07/2020 - 3 minutes
European Biotech Stocks Shine Amid 2020 Market Slump
As the Covid-19 pandemic leads us to the worst financial crisis in decades, normally volatile…
16/07/2020 - 4 minutes
The European Fight Against The Covid-19 Coronavirus
The Covid-19 pandemic continues to grip the world this summer, with many lockdown restrictions remaining…
15/07/2020 - 11 minutes
Osivax Raises €32M to Develop Universal Coronavirus and Influenza Vaccines
Osivax, a Lyon-based biotechnology company, secured €17.5M from the European Innovation Council and €15.1M from…
08/07/2020 - 3 minutes
Remdesivir Becomes the First Covid-19 Treatment Approved in Europe
Remdesivir has received a one-year conditional marketing authorization from the European Commission due to the…
08/07/2020 - 3 minutes
Pfizer-BioNTech Covid-19 Vaccine Shows Phase I Promise
A vaccine made out of messenger RNA (mRNA), developed by the US pharmaceutical giant Pfizer…
03/07/2020 - 3 minutes
Belgian mRNA Vaccine for Covid-19 Receives €34M Series B Boost
Belgian biotech eTheRNA has secured €34M in Series B funding to progress to the clinic…
18/06/2020 - 3 minutes
